FDA Issues: Review & Approval of New Drugs & Other Regulatory Issues
New HIV Drug Dolutegravir Could Soon Be Approved by FDA (February 28, 2013)
From TheBodyPRO.com
What's a Fulyzaq? I Thought You'd Never Ask (January 3, 2013)
From Journal Watch
On TheBodyPRO.com
- FDA Approval of Generic ARVs (November/December 2012)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
- Food and Drug Administration Urged to Speed Approval of Drugs (September 26, 2012)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- FDA Approval of Generic ARVs (July/August 2012)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
On TheBodyPRO.com
- How HIV Drugs Get Approved (August 9, 2012)
To read PDF, click here.
From AIDS InfoNet
- More Than 150 Antiretroviral Drugs Available Through PEPFAR for Worldwide HIV/AIDS Relief (July 23, 2012)
From U.S. Food and Drug Administration
- The FDA Gives Truvada as PreP the Official Okay (July 17, 2012)
In Housing Works AIDS Issues Update, from Housing Works
- Advocates, Policy Experts Respond to FDA Approval of Truvada for HIV Prevention (July 17, 2012)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
Truvada Approved to Reduce the Risk of Sexually Transmitted HIV in People Who Are Not Infected With the Virus (July 16, 2012)
From U.S. Food and Drug Administration
VIEW ALL ARTICLES
|
Advertisement
|